Left cardiac sympathetic denervation for the management of life-threatening ventricular tachyarrhythmias in young patients with catecholaminergic polymorphic ventricular tachycardia and long QT syndrome

Clinical Research in Cardiology

Volumn 102, Issue 1, 2013, Pages 33-42

  Schneider, Heike E ^a   Steinmetz, Michael ^a   Krause, Ulrich ^a   Kriebel, Thomas ^a   Ruschewski, Wolfgang ^a   Paul, Thomas ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Children and young adults; CPVT; Left cardiac sympathetic denervation; Long QT syndrome

Indexed keywords

METOPROLOL; NADOLOL; PROPRANOLOL; RYANODINE RECEPTOR 2;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BODY WEIGHT; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CHILD; CLINICAL ARTICLE; DRUG MEGADOSE; FAINTNESS; FEMALE; GENE MUTATION; GENOTYPE; HEART DENERVATION; HEART DISEASE; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LEFT CARDIAC SYMPATHETIC DENERVATION; LONG QT SYNDROME; MALE; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; RECURRENT DISEASE; SCHOOL CHILD; SURGICAL APPROACH; TREATMENT INDICATION; TREATMENT OUTCOME;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGE FACTORS; ANTI-ARRHYTHMIA AGENTS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEART; HUMANS; LONG QT SYNDROME; MALE; MUTATION; PHENOTYPE; RETROSPECTIVE STUDIES; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SYMPATHECTOMY; TACHYCARDIA, VENTRICULAR; TIME FACTORS; TREATMENT OUTCOME;

EID: 84872362485     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-012-0492-7     Document Type: Article

References (46)

1. Leenhardt A, Lucet V, Denjoy I, Grau F, Ngoc DD, Coumel P (1995) Catecholaminergic polymorphic ventricular tachycardia in children: a 7-year follow-up of 21 patients. Circulation 91:1512-1519
2. Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M, DeSimone L, Coltorti F, Bloise R, Keegan R, Cruz Filho FE, Vignati G, Benatar A, DeLogu A (2002) Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 106:69-74
3. Ackerman MJ (2004) Cardiac channelopathies: it's in the genes. Nat Med 10:463-464
4. Napolitano C, Priori SG (2007) Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 4:675-678
5. Goldenberg I, Moass AJ (2008) Long QT syndrome. J Am Coll Cadiol 51:2291-2300
6. Moss AJ, Zareba W, Hall WJ, Schwartz PJ, Crampton RS, Benhorin J, Vincent GM, Locati EH, Priori SG, Napolitano C, Medina A, Zhang L, Robinson JL, Timothy K, Towbin JA, Andrews ML (2000) Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation 101:616-623
7. Sumitomo N, Harada K, Nagashima M, Yasuda T, Nakamura Y, Aragaki Y, Saito A, Kurosaki K, Jouo K, Koujiro M, Konishi S, Matsuoka S, Oono T, Hajakawa S, Miura M, Ushinohama H, Shibata T, Niimura I (2003) Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death. Heart 89:66-70
8. Swan H, Laitinen P, Kontula K, Toivonen L (2005) Calcium channel antagonism reduces exercised-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RYR2 mutations. J Cardiovasc Electrophys 16:162-166
9. Rosso R, Kalman JM, Rogowski O, Diamant S, Birger A, Biner S, Belhassen B, Viskin S (2007) Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 4:1149-1154
10. Krause U, Gravenhorst V, Kriebel T, Ruschewski W, Paul T (2011) A rare association of long QT syndrome and syndactyly: Timothy syndrome (LQT 8). Clin Res Cardiol 100:1123-1127
11. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M et al., American College of Cardiology/American Heart Association Task Force, European Society of Cardiology Committee for Practice Guidelines, European Heart Rhythm Association, Heart Rhythm Society (2006) ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114:e385-484
12. Mohamed U, Gollob MH, Gow RM, Krahn AD (2006) Sudden cardiac death despite an implantable cardioverter-defibrillator in a young female with catecholaminergic ventricular tachycardia. Heart Rhythm 3:1486-1489
13. Schwartz PJ, Spazzolini C, Priori SG, Crotti L, Vicentini A, Landolina M et al (2010) Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them? Data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry. Circulation 122:1272-1282
14. Schwartz PJ, Locati EH, Moss AJ, Crampton RS, Trazzi R, Ruberti U (1991) Left cardiac sympathetic denervation in the therapy of congenital long QT syndrome. A worldwide report. Circulation 84:503-511
15. Schwartz PJ, Priori SG, Cerrone M, Spazzolini C, Odero A, Napolitano C, Bloise R, De Ferrari GM, Klersy C, Moss AJ, Zareba W, Robinson JL, Hall WJ, Brink PA, Toivonen L, Epstein AE, Li C, Hu D (2004) Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome. Circulation 109:1826-1833
16. Atallah J, Fynn-Thompson F, Cecchin F, DiBardino DJ, Walsh EP, Berul CI (2008) Video-assisted thoracoscopic cardiac denervation: a potential novel therapeutic option for children with intractable ventricular arrhythmias. Ann Thorac Surg 86:1620-1625
17. Collura CA, Johnson JN, Moir C, Ackerman MJ (2009) Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery. Heart Rhythm 6:752-759
18. Wilde AAM, Bhuiyan ZA, Crotti L, Facchini M, De Ferrari GM, Paul T, Ferrandi C, Koolbergen DR, Odero A, Schwartz PJ (2008) Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia. N Engl J Med 358:2024-2029
19. Schwartz PJ, Snebold NG, Brown AM (1976) Effects of unilateral cardiac sympathetic denervation on the ventricular fibrillation threshold. Am J Cardiol 37:1034-1040
20. Schwartz PJ, Stone HL (1982) Left stellectomy and denervation supersensitivity in conscious dogs. Am J Cardiol 49:1185-1190
21. Schwartz PJ (1984) The rationale and the role of left stellectomy for the prevention of malignant arrhythmias. Ann NY Acad Sci 427:199-221
22. Schwartz PJ, Priori SG (2000) Sympathetic nervous system and cardiac arrhythmias. In: Zipes DP, Jalife J (eds) Cardiac electrophysiology: from cell to bedside, 3rd edn. Saunders, Philadelphia, pp 330-343
23. Schwartz PJ (2001) Another role for the sympathetic nervous system in the long QT syndrome? J Cardiovasc Electrophysiol 12:500-502
24. Schwartz PJ, Stone HL (1979) Effects of unilateral stellectomy upon cardiac performance during exercise in dogs. Circ Res 44:637-645
25. Schwartz PJ (2010) Efficacy of left cardiac sympathetic denervation has an unforeseen side effect: medicolegal complications. Heart Rhythm 7:1330-1332
26. Goldenberg I, Bradley J, Moss AJ, McNitt S, Polonsky S, Robinson JL, Andrews M, Zareba W, International LQTS Registry Investigators (2010) Beta-blocker efficacy in high-risk patients with the congenital long-QT syndrome types 1 and 2: implications for patient management. J Cardiovasc Electrophysiol 21:893-901
27. Goldenberg I, Moss AJ, Peterson DR, McNitt S, Zareba W, Andrews ML, Robinson JL, Locati EH, Ackerman MJ, Benhorin J, Kaufman ES, Napolitano C, Priori SG, Qi M, Schwartz PJ, Towbin JA, Vincent GM, Zhang L (2008) Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome. Circulation 117:2184-2191
28. Schwartz PJ, Spazzolini C, Crotti L (2009) All LQT3 patients need an ICD: true or false? Heart Rhythm 6:113-120
29. Chatrath R, Bell CM, Ackerman M (2004) β-Blocker failures in symptomatic probands with genotyped long-QT syndrome. Pediatric Cardiol 25:459-465
30. Priori SG, Napolitano C, Schwartz PJ, Massimiliano G, Bloise R, Ronchetti E (2004) Association of long QT syndrome loci and cardiac events among patients treated with β-blockers. JAMA 292:1341134
31. Atkins HJB (1949) Peraxillary approach to the stellate and upper thoracic sympathetic ganglia. Lancet 254:1152
32. Odero A, Bozzani A, De Ferrari GM, Schwartz PJ (2010) Left cardiac sympathetic denervation for the prevention of life-threatening arrhythmias: the surgical supraclavicular approach to cervicothoracic sympathectomy. Heart Rhythm 7:1161-1165
33. Gossot D, Kabiri H, Caliandro R, Debrosse D, Girard D, Grunenwald D (2001) Early complications of thoracic endoscopic sympathectomy: a prospective study of 940 procedures. Ann Thorac Surg 71:1116-1119
34. Ukena C, Bauer A, Mahfoud F, Schreieck J, Neuberger HR, Eick C, Sobotka PA, Gawaz M, Böhm M (2012) Renal sympathetic denervation for the treatment of electrical storm: first-in-man experience. Clin Res Cardiol 101:63-67
35. Rosso R, Kalman JM, Rogowsky O, Diamant S, Birger A, Biner S, Belhassen B, Viskin S (2010) Long-term effectiveness of beta blocker and calcium channel blocker combination therapy in patients with CPVT. Heart Rhythm 7:S423
36. Sy RW, Gollob MH, Klein GJ, Yee R, Skanes AC, Gula LJ, Leong-Sit P, Gow RM, Green MS, Birnie DH, Krahn AD (2011) Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 8:864-871
37. van der Werff C, Kannankeril PJ, Sacher F, Krahn AD, Viskin S, Leenhardt A, Shimizi W, Sumitomo N, Fish FA, Bhuiyan ZA, Willems AR, van der Veen MJ, Watanabe H, Laborderie J, Haissaguerre M, Knollmann BC, Wilde AA (2011) Flecainide therapy reduces exercised-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia. J Am Coll Cardiol 57:2244-2254
38. Watanabe H, Chopra N, Laver D, Hwang HS, Davies SS, Roach DE, Duff HJ, Roden DM, Wilde AA, Knollmann BC (2009) Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans. Nat Med 15:380-383
39. 2+ spark mass. J Mol Cell Cardiol 48:293-301
40. Schwartz PJ (2009) Cutting nerves and saving lives. Heart Rhythm 6:760-763
41. Svendsen JH, Geelen P, EHRA Scientific Initiative Commitee (2010) Screening for, and management of, possible arrhythmogenic syndromes (channelopathies/ion channel diseases). Europace 12:741-742
42. Veltmann C, Schimpf R, Borggrefe M, Wolpert C (2009) Risk stratification in electrical cardiomyopathies. Herz 34:518-527
43. Moray A, Krik EP, Grant P, Camphausen C (2011) Prophylactic left thoracic sympathectomy to prevent electrical storms in patients with CPVT needing ICD placement. Heart Lung Circ 20:731-733
44. Gopinathannair R, Olshansky B, Iannettoni M, Mazur A (2010) Delayed maximal response to left cardiac sympathectomy for catecholaminergic polymorphic ventricular tachycardia. Europace 12:1035-1039
45. Scott PA, Sandilands AJ, Morris GE, Morgan JM (2008) Successful treatment of catecholaminergic polymorphic ventricular tachycardia with bilateral thoracoscopic sympathectomy. Heart Rhythm 5:1461-1463
46. Makanjee B, Gollob MH, Klein GJ, Krahn AD (2009) Ten-year follow-up of cardiac sympathectomy in a young woman with catecholaminergic polymorphic ventricular tachycardia and an implantable cardioverter defibrillator. J Cardiovasc Electrophysiol 20:1167-1169